Purdue Professors Craig Goergen and Guang Lin team up with medical centers around the country and receive $3.6 Million NIH grant to improve heart disease detection in kids with Duchenne Muscular Dystrophy using advanced imaging and machine learning.

Robinson reports on developments in portable foodborne pathogen and blood-based disease detection in his presentation to the Purdue Board of Trustees.

Adipo is a privately held, late-stage, preclinical biopharmaceutical company developing a breakthrough approach to treat the dual epidemics of obesity and Type 2 diabetes. Adipo has identified a lead asset, ADPO-002, that combines a notch inhibitor with novel nanoparticle technology. ADPO-002 is specifically designed to infiltrate and release the active ingredient inside the cellular structure of white adipose tissue, which results in mitochondrial biogenesis and the beiging of white adipose tissue. Meng Deng is the founder and president of Adipo Therapeutics. He also is an associate professor in Purdue University’s Department of Agricultural and Biological Engineering, Weldon School of Biomedical Engineering and School of Materials Engineering.

He may be an MD, not a PhD, but his research on the development of individualized digital biomarkers made possible by wearable sensors may change the face of healthcare.

Hugh Lee is one of four researches at Purdue to receive the Trask Innovation Fund. The fund awards up to $50,000 for short-term projects that enhance the commercial value of Purdue intellectual property.

VIP team designs Narcan delivery drone to bring aid to remote communities

Hyowon (Hugh) Lee, an associate professor in the Weldon School of Biomedical Engineering, for receiving a patent on his intellectual property, “Drug Delivery Device and Method.”

Park’s specialization is on controlled release, long-acting injectables, PLGA formulations and hydrogels.

Working on research funded in part by Indiana CTSI, Jacqueline Linnes, the Marta E. Gross Associate Professor of Biomedical Engineering, is developing a low-cost, paper-based test for cervical cancer. (Purdue University photo/Charles Jischke)

Infants and children are not scaled down versions of adults. The simple mantra led to The Crossroads Pediatric Device Consortium.